Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 12,007 | 14,196 | 13,479 | 12,228 | 12,319 |
| Cost of Goods | 6,219 | 6,689 | 8,034 | 7,318 | 6,776 |
| Gross Profit | 5,788 | 7,507 | 5,445 | 4,910 | 5,543 |
| Operating Expenses | 10,773 | 12,416 | 11,615 | 11,281 | 14,027 |
| Operating Income | -4,766 | -4,220 | -6,136 | -6,052 | -7,708 |
| Other Income | 30 | -180 | 15 | -9 | 52 |
| Pre-tax Income | -4,736 | -4,400 | -6,121 | -6,062 | -7,656 |
| Net Income Continuous | -4,736 | -4,500 | -6,121 | -6,062 | -7,656 |
| Net Income | $-4,736 | $-4,500 | $-6,121 | $-6,062 | $-7,656 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| EBITDA(a) | $-4,272 | $-3,742 | $-5,653 | $-5,570 | $-7,291 |